Answers are grounded in this paper and cite their sources.
Pre-clinical R&D intelligence is fragmented across PubMed, ChEMBL, patent offices, AlphaFold, and DepMap. A generalist LLM can summarise the surface of these sources, but the question that drives a portfolio decision — which targets are biologically supported, under-developed, and tractable for a chosen modality — requires typed traversal across all of them at once, and a prose answer cannot carry the structured scaffold such a decision needs. We present Mosaic, an open Model-Context-Protocol (MCP) tool surface over a curated knowledge graph (Postgres + Apache AGE + pgvector) shipping with an oncology starter corpus chosen to validate the architecture on one tractable therapy area before widening: 363 targets, 12,756 compounds, 35,430 papers, 14,305 patents, and roughly 736K typed edges. The schema and pipeline are therapy-area-agnostic; cardiovascular expansion is in flight. The tools are the product; the web UI is one delivery surface among several. Methods include zero-shot GLiREL relation extraction (precision evaluated on a stratified human-reviewed sample), Foldseek structural similarity over the AlphaFold corpus, and a heuristic SMILES modality classifier. On twelve first-order benchmark questions the MCP-armed agent cites roughly four times as many concrete, mechanically valid identifiers as a no-tool baseline with zero invalid IDs in either arm; a date-aware LLM judge gives a 33% win-rate (~58% after verified judge-error correction). Across five case studies, Mosaic's advantage is consistently a structured-output one — per-row evidence, an explicit ranking criterion, and auditable identifiers — that holds even where a web-armed frontier LLM recovers comparable prose recall. The production knowledge graph is released as a versioned public data archive, and the live MCP server and reproducibility package are publicly available; the production source code is held privately and made available to peer reviewers on request (https://getmosaic.dev).
No takes yet. Share an insight, caveat, or question.
Sourabh Nyalkalkar (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: